Published in Infect Immun on December 01, 1995
Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum (2010) 2.53
Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol (1996) 1.69
Hemoglobinase activity of the lysine gingipain protease (Kgp) of Porphyromonas gingivalis W83. J Bacteriol (1999) 1.51
The chymotrypsin-like protease complex of Treponema denticola ATCC 35405 mediates fibrinogen adherence and degradation. Infect Immun (2007) 1.02
Proteolysis of CD14 on human gingival fibroblasts by arginine-specific cysteine proteinases from Porphyromonas gingivalis leading to down-regulation of lipopolysaccharide-induced interleukin-8 production. Infect Immun (2002) 1.02
Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV. Infect Immun (2000) 0.97
Bifunctional role of the Treponema pallidum extracellular matrix binding adhesin Tp0751. Infect Immun (2010) 0.97
Kinin danger signals proteolytically released by gingipain induce Fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis. J Immunol (2009) 0.94
Outer membrane vesicles of Porphyromonas gingivalis elicit a mucosal immune response. PLoS One (2011) 0.94
Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues. Antimicrob Agents Chemother (2001) 0.92
Arginine-specific gingipains from Porphyromonas gingivalis deprive protective functions of secretory leucocyte protease inhibitor in periodontal tissue. Clin Exp Immunol (2006) 0.88
Functional implication of the hydrolysis of platelet endothelial cell adhesion molecule 1 (CD31) by gingipains of Porphyromonas gingivalis for the pathology of periodontal disease. Infect Immun (2005) 0.87
Relationship of Specific Bacteria in the Cervical and Vaginal Microbiotas With Cervicitis. Sex Transm Dis (2015) 0.81
Impaired plasma clottability induction through fibrinogen degradation by ASP, a serine protease released from Aeromonas sobria. FEMS Microbiol Lett (2008) 0.80
Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis. J Innate Immun (2015) 0.77
Gingipains of Porphyromonas gingivalis Affect the Stability and Function of Serine Protease Inhibitor of Kazal-type 6 (SPINK6), a Tissue Inhibitor of Human Kallikreins. J Biol Chem (2016) 0.75
Porphyromonas gingivalis-derived outer membrane vesicles promote calcification of vascular smooth muscle cells through ERK1/2-RUNX2. FEBS Open Bio (2016) 0.75
Fibrinogen Degradation Products and Periodontitis: Deciphering the Connection. J Clin Diagn Res (2015) 0.75
Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res (1984) 5.29
Biology of asaccharolytic black-pigmented Bacteroides species. Microbiol Rev (1988) 4.17
Fibrinogen and fibrin. Annu Rev Biochem (1984) 3.35
Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem (1994) 2.90
Selective removal of albumin from plasma by affinity chromatography. Clin Chim Acta (1973) 2.69
Selected characteristics of pathogenic and nonpathogenic strains of Bacteroides gingivalis. J Clin Microbiol (1987) 2.19
The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun (1995) 2.03
Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem (1992) 1.99
Degradation of albumin, haemopexin, haptoglobin and transferrin, by black-pigmented Bacteroides species. J Med Microbiol (1984) 1.91
Bacteroides gingivalis and Bacteroides intermedius recognize different sites on human fibrinogen. J Bacteriol (1990) 1.69
Fibrinolytic activity of oral anaerobic bacteria. Arch Oral Biol (1978) 1.65
Purification and characterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from Porphyromonas gingivalis that cleaves kininogens and fibrinogen. J Biol Chem (1993) 1.61
Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest (1994) 1.56
Thrombin. Ann N Y Acad Sci (1986) 1.44
Specific cell components of Bacteroides gingivalis mediate binding and degradation of human fibrinogen. J Bacteriol (1991) 1.42
Inactivation of key factors of the plasma proteinase cascade systems by Bacteroides gingivalis. Infect Immun (1985) 1.32
Human plasminogen. Methods Enzymol (1981) 1.26
Ultrastructure and enzyme activities of a virulent and an avirulent variant of Bacteroides gingivalis W50. FEMS Microbiol Lett (1989) 1.21
Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis. Infect Immun (1995) 1.17
The distribution of trypsin-like enzyme activity in cultures of a virulent and an avirulent strain of Bacteroides gingivalis W50. Oral Microbiol Immunol (1989) 1.15
Interactions of Bacteroides gingivalis with fibrinogen. Infect Immun (1986) 1.11
Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen. Thromb Haemost (1981) 1.05
Fibrinogenolytic and fibrinolytic activity in oral microorganisms. J Clin Microbiol (1983) 1.04
The chemotactic activity of fibrin lysis products. Int Arch Allergy Appl Immunol (1972) 0.94
Fibrinogen degradation product fragment D increases endothelial monolayer permeability. Am J Physiol (1991) 0.90
The effect of 2% chlorhexidine digluconate irrigation on clinical parameters and the level of Bacteroides gingivalis in periodontal pockets. J Periodontol (1989) 0.89
Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E. J Clin Invest (1989) 0.87
Clinical, microbiological, and immunological studies following initial preparation in adult periodontitis. Bull Tokyo Dent Coll (1990) 0.85
Characterization of fibronectin and fibrin(ogen) fragments in gingival crevicular fluid. Scand J Dent Res (1993) 0.80
In vitro preparation and partial characterization of a novel complex of human fibrinogen with albumin. J Protein Chem (1995) 0.78
Plasminogen activator in periodontal health and disease. Ann N Y Acad Sci (1992) 0.77
Human plasma proteinase inhibitors. Annu Rev Biochem (1983) 6.61
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81
The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med (1982) 3.69
Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry (1976) 3.57
Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res (2000) 3.55
Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem (1980) 3.14
The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci U S A (1997) 3.09
The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem (1994) 3.07
Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis (1982) 2.96
Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem (1994) 2.90
Selective removal of albumin from plasma by affinity chromatography. Clin Chim Acta (1973) 2.69
The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J Biol Chem (1979) 2.57
Primary structure of human neutrophil elastase. Proc Natl Acad Sci U S A (1987) 2.45
Isolation and properties of human plasma alpha-1-proteinase inhibitor. Biochemistry (1974) 2.40
Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 (2000) 2.29
Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry (1987) 2.24
Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma. Biochem J (1976) 2.15
The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun (1995) 2.03
Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun (1979) 2.00
Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem (1992) 1.99
Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol Chem (1995) 1.98
Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem (1992) 1.96
Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun (1999) 1.96
Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis. J Periodontal Res (1999) 1.90
Why Eric Mazur Brings Chaos--Not Chaos Theory--to Physics. Science (1994) 1.87
Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor. J Biol Chem (1978) 1.79
Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J (1999) 1.79
Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood (2001) 1.77
X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J (1986) 1.76
Isolation and properties of human neutrophil myeloperoxidase. Biochemistry (1981) 1.71
Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol (1996) 1.69
Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis. J Biol Chem (1998) 1.68
Reviving the antibiotic miracle? Science (1994) 1.67
Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest (1994) 1.56
Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluid. Biochem Biophys Res Commun (1980) 1.56
Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J Biol Chem (2001) 1.56
Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodontal Res (1997) 1.56
Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem (1982) 1.51
Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (gingipains) using peptidyl chloromethanes. Biol Chem (1997) 1.48
Scoring a technical knockout in mice. Science (1992) 1.45
Purification of human alpha-2-macroglobulin by chromatography on Cibacron Blue Sepharose. Anal Biochem (1978) 1.44
Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J Biol Chem (1998) 1.43
Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases. J Biol Chem (1997) 1.43
The degradation of human lung elastin by neutrophil proteinases. Biochim Biophys Acta (1980) 1.40
Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett (1988) 1.39
Are bacterial proteinases pathogenic factors? Trends Microbiol (1995) 1.39
Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease. Clin Infect Dis (1999) 1.39
Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J Biol Chem (1990) 1.38
Army targets a potential vaccine against cholesterol. Science (1993) 1.38
Porphyromonas gingivalis: a proteinase/gene accounting audit. Trends Microbiol (1995) 1.38
The degradation of human glomerular basement membrane with purified lysosomal proteinases: evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis. Clin Sci Mol Med (1978) 1.38
Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun (2001) 1.35
Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett (1998) 1.33
Structural and functional characterization of the abnormal Z alpha 1-antitrypsin isolated from human liver. FEBS Lett (1984) 1.24
Bacterial proteinases as targets for the development of second-generation antibiotics. Biochim Biophys Acta (2000) 1.23
Primary structure of the reactive site of human C1-inhibitor. J Biol Chem (1985) 1.23
Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases. Biochemistry (1978) 1.21
Uroperitoneum in the hospitalised equine neonate: retrospective study of 31 cases, 1988-1997. Equine Vet J (2000) 1.20
Molecular uniformity in biological catalyses. The enzymes concerned with firefly luciferin, amino acid, and fatty acid utilization are compared. Science (1967) 1.19
Genetic and environmental variation in the visual properties of bluefin killifish, Lucania goodei. J Evol Biol (2005) 1.17
Inactivation of human alpha 1-proteinase inhibitor by thiol proteinases. Biochem J (1977) 1.17
Cleaved antitrypsin polymers at atomic resolution. Protein Sci (2000) 1.17
Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol (2008) 1.17
The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J (1996) 1.17
Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis. Infect Immun (1995) 1.17
Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett (1998) 1.16
Interaction of human alpha-1-proteinase inhibitor with neutrophil myeloperoxidase. Biochemistry (1981) 1.16
Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect Immun (1996) 1.15
Degradation of host heme proteins by lysine- and arginine-specific cysteine proteinases (gingipains) of Porphyromonas gingivalis. J Bacteriol (2001) 1.14
Population variation in opsin expression in the bluefin killifish, Lucania goodei: a real-time PCR study. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2003) 1.14
A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect Immun (1998) 1.14
Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem Biophys Res Commun (1999) 1.13